Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pathophysiology of aplastic anaemia.

C Nissen-Druey

    Bailliere'S Clinical Haematology
    |January 1, 1989
    PubMed
    Summary

    Aplastic anaemia likely results from a premalignant hematopoietic disorder that triggers an immune response, potentially representing a

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Pathophysiology of aplastic anaemia.

    Blood reviews·1990
    Same author

    Human recombinant hemopoietic growth factors G-CSF and GM-CSF: first results of clinical trials.

    Nouvelle revue francaise d'hematologie·1989
    Same author

    Myeloid differentiation in cultures of human hemopoietic precursor cells.

    Blut·1979
    Same author

    Differential counts of neutrophil, eosinophil, and macrophage colonies in cultures from human bone marrow and peripheral blood.

    Blut·1978
    Same author

    [T-infarct in exercise electrocardiography].

    Schweizerische medizinische Wochenschrift·1975
    Same author

    [Significance of non-specific T changes in the Master electrocardiogram].

    Schweizerische medizinische Wochenschrift·1974

    Area of Science:

    • Hematology
    • Immunology
    • Oncology

    Background:

    • Aplastic anaemia (AA) pathogenesis remains unclear, with neither intrinsic hematopoietic defects nor immune effects alone fully explaining the disease.
    • The intrinsic defect is insufficient to cause severe pancytopenia, while immune mechanisms alone do not account for complete recovery post-immunosuppression.

    Purpose of the Study:

    • To investigate the dualistic pathophysiological model of aplastic anaemia involving an intrinsic premalignant hematopoietic defect and a secondary immune response.
    • To reconcile the varied clinical presentations and treatment responses in aplastic anaemia under a unified etiological framework.

    Main Methods:

    • Analysis of in vitro studies from a cohort of aplastic anaemia patients at various disease stages.
    • Comparison of clinical presentations, responses to immunosuppressive therapy, and outcomes in different patient subgroups.

    Main Results:

    • Aplastic anaemia is proposed to stem from a premalignant hematopoietic disorder that can either be quiescent or trigger an autoimmune reaction.
    • The disease may represent the body's attempt to 'self-cure' a preleukemic condition, aligning with the concept of AA as a hypoplastic variant of leukemia.
    • Variations in clinical course and treatment response are attributed to the balance between the intrinsic defect and immune reaction, repair efficiency, and co-involved cells.

    Conclusions:

    • A unified pathophysiological model explains most aplastic anaemia cases, including drug- and virus-induced forms.
    • A subset of patients with drug-induced pancytopenia may have a truly benign, reversible form of aplastic anaemia.
    • The findings suggest aplastic anaemia might be a complex interplay between a premalignant condition and the immune system's response.

    Related Experiment Videos